Denver, CO – Schryver Medical Sales and Marketing, LLC (“Schryver”), a portfolio company of Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, has completed the acquisitions of Main Street Clinical Laboratory, Inc. (“Main Street”) and On-Site Imaging Solutions, Inc. (“On-Site”).
Schryver, headquartered in Denver, Colorado, is a JCAHO accredited provider of mobile imaging diagnostics, clinical laboratory services, oxygen therapy and durable medical equipment rental. Schryver serves nearly 3,000 long term post-acute facilities, assisted-living centers, and skilled nursing facilities, as well as numerous homecare patients. Schryver’s significant value proposition and service line diversity have resulted in long term customer relationships and a superior brand reputation. These two acquisitions follow Schryver’s January 2015 acquisition of Nashville-based Quality Mobile X-Ray.
Based in Southaven, Mississippi, Main Street is a fully licensed, CLIA Certified clinical laboratory, providing a comprehensive test menu of laboratory services to physicians and other healthcare providers. Main Street delivers the results and information that allow their clients to make the decisions for the best treatment of their patients. Main Street’s service area includes Mississippi, Tennessee and Arkansas.
On-Site, which is based in Little Rock, Arkansas, provides mobile imaging solutions to nursing homes, healthcare facilities, hospice centers, correctional facilities and home health patients throughout Arkansas. On-Site offers EKG, ultrasound, and cardiac imaging services utilizing state-of-the-art digital technology with continual quality assurance monitoring to ensure superb image quality. On-Site maintains 24/7/365 support services and has an average report turnaround time of 25 minutes.
“We are excited to see our operations in the southeastern United States expand,” said Doug Goetz, CEO of Schryver. “Main Street and On-Site are both very strategic to our goals and support the momentum we have gained in the southeast. These transactions serve as important steps in our continued effort to grow the Schryver footprint and offer superior services at a national level.”
“The resources, expertise, and strategy that Schryver has leveraged in building its reputation as a market leader will translate into continued success,” commented Mark King, CEO, Managing Partner and Co-Founder of Revelstoke. “We are pleased by the Schryver team’s continued ability to identify and integrate add-on opportunities.”
Perkins Coie LLP and Winston & Strawn LLP acted as legal advisors to Schryver. Hyden, Miron & Foster, PLLC acted as legal advisor to On-Site in their transaction.
Based in Denver, Colorado, and employing more than 500 professionals, Schryver is a leading provider of mobile imaging, clinical laboratory, and oxygen therapy equipment outsourcing in the western United States serving the long term care market, hospitals, assisted-living centers, and homecare patients. www.schryvermedical.com
Revelstoke is a private equity firm formed by experienced investors who focus on building exceptional industry-leading companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build industry-leading companies and generate superior investment returns for management owners and investor partners. Revelstoke’s Managing Partners, Mark King, Dale Meyer and Simon Bachleda, have more than six decades of combined private equity investing and capital formation experience having completed more than 100 platform and add-on acquisitions, representing more than $6 billion of total enterprise value.